PPM1D and breast carcinoma: Although our study does not address the effect of Wip1 over-expression in tumor cells, our data do suggest that it would be worthwhile to explore the use of Wip1 inhibitors for preventive treatment, similar to the recently approved use of tamoxifen in women with a high risk of breast cancer [55,68].